Stryker Corporation (SYK) financial statements and ratios from SEC XBRL: revenue $25.12B (TTM), net margin 12.9%, revenue growth 9.4% YoY, P/E 33.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $25.12B |
| Net Margin | 12.9% |
| Revenue Growth (YoY) | 9.4% |
| EPS Growth (YoY) | 43.1% |
| FCF Growth (YoY) | 14.1% |
| P/E Ratio | 33.8 |
| EV / EBITDA | 19.2 |
| Price / Book | 5.25 |
| Price / Sales | 4.88 |
| FCF Yield | 3.7% |
| DCF Value (model) | $89.33 |
| DCF Upside vs Price | -72.8% |
| Altman Z-Score | 4.60 (safe) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
SYK overview · SYK earnings · SYK KPIs · SYK investor relations · SYK ownership · SYK peers · SYK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.